NA radiotherapy market - Industry Trends and Forecast to 2032
- Published Date: 2022-11-22
- Report ID: 144378
- Pages: 200
-
Format:
Short Description
North America Radiotherapy Market, By Type (External-Beam Radiation Therapy, Internal Radiation Therapy, Systemic Radiotherapy/ Radiopharmaceuticals, Others), Product (External Beam Radiotherapy, Internal Radiotherapy Products, Radiotherapy Software, Systemic Radiotherapy, Others), Application (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Lymphoma, Liver Cancer, Thyroid Cancer, Brain Cancer, Cervical Cancer, Spine Cancer, Others), End User (Hospitals, Radiation Therapy Centers, Specialty Clinics, Others), Distribution Channel (Direct Tender, Retail Sales, Others), Country (U.S., Canada, Mexico), Industry Trends and Forecast to 2029
Market Definition
Radiotherapy is a type of treatment procedure that is mainly used to treat cancer disease by the usage of X-rays and similar forms of radiation technology. The method and procedure of radiotherapy have been advanced in terms of launching new treatment planning software and advanced features-based therapy modalities.
In radiotherapy treatment, high-energy based radiation rays are often used to damage cancer cells and stop them from growing and dividing. External radiation therapy has numerous types of advanced technology which is used in the treatment of cancer. External radiation therapy comprised of three-dimensional conformal radiation therapy (3D-CRT), intensity-modulated radiation therapy (IMRT), proton beam therapy, image-guided radiation therapy (IGRT), stereotactic radiation therapy, and volumetric modulated ARC therapy (VMAT), among others.
Market Segmentation
North America radiotherapy market is categorized into five notable segments which are based on type, product, application, end user, and distribution channel.
On the basis of type, the North America radiotherapy market is segmented into external-beam radiation therapy, internal radiation therapy, systemic radiotherapy/radiopharmaceuticals, and others
On the basis of product, the North America radiotherapy market is segmented into external beam radiotherapy, internal radiotherapy products, radiotherapy software, systemic radiotherapy, and others
On the basis of application, the North America radiotherapy market is segmented into breast cancer, lung cancer, prostate cancer, colorectal cancer, lymphoma, liver cancer, thyroid cancer, brain cancer, cervical cancer, spine cancer, and others
On the basis of end user, the North Americal radiotherapy market is segmented into hospitals, radiation therapy centers, specialty clinics, and others
On the basis of distribution channel, the North America radiotherapy market is segmented into direct tender, retail sales, and others
Market Players
Some of the key market players for the North America radiotherapy market are listed below:
CANON MEDICAL SYSTEMS CORPORATION
ProTom International
Mevion Medical Systems
VIEWRAY TECHNOLOGIES, INC. (VIEWRAY)
Elekta AB (pub)
Accuray Incorporated
IBA Worldwide
Eckert & Zeigler BEBIG
Xoft, a subsidiary of iCAD, Inc.
RaySearch Laboratories
Brainlab
Advanced Oncotherapy
Hitachi, LTD.
Advanced Accelerator Applications (A Subsidiary of Novartis AG)
Provision Healthcare
Nordion (Canada) Inc. (A Subsidiary of Sotera Health)
Sumitomo Heavy Industries, Ltd.
Isoray Inc.
Siemens Healthcare GmbH
Koninklijke Philips N.V.
IntraOp Medical, Inc.
Ariane Medical Systems Ltd
ZEISS International
General Electric Company
SIT-S.I.T. Sordina IORT Technologies S.p.A.
CIVCO Radiotherapy
TABLE OF CONTENTS
1 INTRODUCTION 40
1.1 OBJECTIVES OF THE STUDY 40
1.2 MARKET DEFINITION 40
1.3 OVERVIEW OF NORTH AMERICA RADIOTHERAPY MARKET 40
1.4 LIMITATIONS 42
1.5 MARKETS COVERED 42
2 MARKET SEGMENTATION 45
2.1 MARKETS COVERED 45
2.2 GEOGRAPHICAL SCOPE 46
2.3 YEARS CONSIDERED FOR THE STUDY 47
2.4 CURRENCY AND PRICING 47
2.5 DBMR TRIPOD DATA VALIDATION MODEL 48
2.6 MULTIVARIATE MODELLING 51
2.7 TYPE LIFELINE CURVE 51
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 52
2.9 DBMR MARKET POSITION GRID 53
2.10 VENDOR SHARE ANALYSIS 55
2.11 MARKET APPLICATION COVERAGE GRID 56
2.12 SECONDARY SOURCES 57
2.13 ASSUMPTIONS 57
3 EXECUTIVE SUMMARY 58
4 PREMIUM INSIGHTS 61
4.1 PESTEL ANALYSIS 63
4.2 PORTER'S 5 FORCES 64
5 REGULATIONS 65
5.1 BRACHYTHERAPY DEVICES REGULATIONS: 65
5.2 USE OF SOURCES FOR MANUAL BRACHYTHERAPY. 65
5.3 BRACHYTHERAPY SOURCES ACCOUNTABILITY. 65
5.4 EUROPE MEDICAL AGENCY REGULATION 66
5.5 UK 66
5.6 INDIA: 67
6 MARKET OVERVIEW 68
6.1 DRIVERS 70
6.1.1 GROWING PREVALENCE OF CANCER DISEASE 70
6.1.2 NOVEL TECHNOLOGY IN RADIOTHERAPY FOR CANCER TREATMENT 74
6.1.3 INCREASING ADOPTION OF RADIOTHERAPY DEVICES AND PROCEDURES 75
6.1.4 RISING PREFERENCE FOR NON-SURGICAL PROCEDURES 75
6.2 RESTRAINTS 76
6.2.1 LACK OF SKILLED AND CERTIFIED PROFESSIONALS 76
6.2.2 COMPLEX NATURE OF RADIOTHERAPY 76
6.2.3 HIGH COST OF RADIOTHERAPY PROCEDURE 77
6.3 OPPORTUNITIES 77
6.3.1 INCREASING HEALTHCARE EXPENDITURE FOR CANCER TREATMENT 77
6.3.2 GROWING GOVERNMENT INITIATIVES TOWARDS CANCER TREATMENT 80
6.3.3 RISING PATIENTS AWARENESS TOWARDS CANCER TREATMENT 80
6.4 CHALLENGES 81
6.4.1 STRICT REGULATIONS AND STANDARDS FOR APPROVAL AND COMMERCIALIZATION OF RADIOTHERAPY PRODUCTS 81
6.4.2 RISK OF RADIATION EXPOSURE 82
7 IMPACT OF COVID-19 ON NORTH AMERICA RADIOTHERAPY MARKET 83
7.1 IMPACT ANALYSIS ON DEMAND 83
7.2 CONCLUSION 83
8 NORTH AMERICA RADIOTHERAPY MARKET, BY TYPE 84
8.1 OVERVIEW 85
8.2 EXTERNAL-BEAM RADIATION THERAPY 88
8.2.1 IMAGE-GUIDED RADIATION THERAPY (IGRT) 89
8.2.2 PROTON BEAM THERAPY 89
8.2.3 STEREOTACTIC RADIATION THERAPY 89
8.2.4 INTENSITY MODULATED RADIATION THERAPY (IMRT) 89
8.2.5 THREE-DIMENSIONAL CONFORMAL RADIATION THERAPY (3D-CRT) 89
8.2.6 VOLUMETRIC MODULATED ARC THERAPY (VMAT) 89
8.2.7 OTHERS 90
8.3 INTERNAL RADIATION THERAPY 90
8.3.1 BRACHYTHERAPY 91
8.3.1.1 HIGH DOSE BRACHYTHERAPY 91
8.3.1.2 LOW DOSE BRACHYTHERAPY 91
8.3.2 SELECTIVE INTERNAL RADIATION THERAPY (SIRT) 91
8.4 SYSTEMIC RADIOTHERAPY/ RADIOPHARMACEUTICALS 92
8.5 OTHERS 92
9 NORTH AMERICA RADIOTHERAPY MARKET, BY PRODUCT 94
9.1 OVERVIEW 95
9.2 EXTERNAL BEAM RADIATION THERAPY 98
9.2.1 LINAC 99
9.2.2 PROTON THERAPY 99
9.2.2.1 SYNCHROTRON 99
9.2.2.2 CYCLOTRON 99
9.2.3 CYBER KNIFE 99
9.2.4 GAMMA KNIFE 100
9.2.5 OTHERS 100
9.3 INTERNAL RADIOTHERAPY PRODUCTS 100
9.3.1 SEEDS 101
9.3.2 ELECTRONIC BRACHYTHERAPY 101
9.3.3 APPLICATORS 101
9.3.4 AFTERLOADERS 101
9.3.5 OTHERS 101
9.4 RADIOTHERAPY SOFTWARE 101
9.4.1 IMAGE GUIDING SOFTWARE 102
9.4.2 TREATMENT PLANNING SOFTWARE 102
9.4.3 PATIENT POSITIONING SOFTWARE 102
9.4.4 DOSAGE PLANNING SOFTWARE 103
9.4.5 OTHERS 103
9.5 SYSTEMIC RADIOTHERAPY 103
9.5.1 ALPHA EMITTERS 104
9.5.2 BETA EMITTERS 104
9.6 OTHERS 104
10 NORTH AMERICA RADIOTHERAPY MARKET, BY APPLICATION 105
10.1 OVERVIEW 106
10.2 BREAST CANCER 110
10.3 LUNG CANCER 111
10.4 PROSTATE CANCER 112
10.5 COLORECTAL CANCER 113
10.6 LYMPHOMA 114
10.7 LIVER CANCER 115
10.8 THYROID CANCER 116
10.9 BRAIN CANCER 116
10.10 CERVICAL CANCER 117
10.11 SPINE CANCER 118
10.12 OTHERS 119
11 NORTH AMERICA RADIOTHERAPY MARKET, BY END USER 120
11.1 OVERVIEW 121
11.2 HOSPITALS 124
11.3 RADIATION THERAPY CENTERS 124
11.4 SPECIALTY CLINICS 125
11.5 OTHERS 126
12 NORTH AMERICA RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL 127
12.1 OVERVIEW 128
12.2 DIRECT TENDER 131
12.3 RETAIL SALES 131
12.4 OTHERS 132
13 NORTH AMERICA RADIOTHERAPY MARKET, BY REGION 133
13.1 NORTH AMERICA 134
13.1.1 U.S. 142
13.1.2 CANADA 146
13.1.3 MEXICO 150
14 NORTH AMERICA RADIOTHERAPY MARKET: COMPANY LANDSCAPE 154
14.1 COMPANY SHARE ANALYSIS: NORTH AMERICA 154
15 SWOT ANALYSIS 155
16 COMPANY PROFILE 156
16.1 SIEMENS HEALTHCARE GMBH 156
16.1.1 COMPANY SNAPSHOT 156
16.1.2 REVENUE ANALYSIS 156
16.1.3 COMPANY SHARE ANALYSIS 157
16.1.4 PRODUCT PORTFOLIO 157
16.1.5 RECENT DEVELOPMENT 158
16.2 ELEKTA AB (PUB) 159
16.2.1 COMPANY SNAPSHOT 159
16.2.2 RECENT FINANCIALS 159
16.2.3 COMPANY SHARE ANALYSIS 160
16.2.4 PRODUCT PORTFOLIO 160
16.2.5 RECENT DEVELOPMENT 161
16.3 ACCURAY INCORPORATED 162
16.3.1 COMPANY SNAPSHOT 162
16.3.2 RECENT FINANCIALS 162
16.3.3 COMPANY SHARE ANALYSIS 163
16.3.4 PRODUCT PORTFOLIO 163
16.3.5 RECENT DEVELOPMENT 163
16.4 GENERAL ELECTRIC COMPANY 164
16.4.1 COMPANY SNAPSHOT 164
16.4.2 REVENUE ANALYSIS 164
16.4.3 COMPANY SHARE ANALYSIS 165
16.4.4 PRODUCT PORTFOLIO 165
16.4.5 RECENT DEVELOPMENT 165
16.5 IBA WORLDWIDE 166
16.5.1 COMPANY SNAPSHOT 166
16.5.2 RECENT FINANCIALS 166
16.5.3 COMPANY SHARE ANALYSIS 167
16.5.4 PRODUCT PORTFOLIO 167
16.5.5 RECENT DEVELOPMENT 167
16.6 ADVANCED ACCELERATOR APPLICATIONS (A SUBSIDIARY OF NOVARTIS AG) 168
16.6.1 COMPANY SNAPSHOT 168
16.6.2 REVENUE ANALYSIS 168
16.6.3 PRODUCT PORTFOLIO 169
16.6.4 RECENT DEVELOPMENT 169
16.7 ADVANCED ONCOTHERAPY 170
16.7.1 COMPANY SNAPSHOT 170
16.7.2 PRODUCT PORTFOLIO 170
16.8 ARIANE MEDICAL SYSTEMS LTD 171
16.8.1 COMPANY SNAPSHOT 171
16.8.2 PRODUCT PORTFOLIO 171
16.8.3 RECENT DEVELOPMENT 171
16.9 BRAINLAB 172
16.9.1 COMPANY SNAPSHOT 172
16.9.2 PRODUCT PORTFOLIO 172
16.9.3 RECENT DEVELOPMENT 172
16.10 CANON MEDICAL SYSTEMS CORPORATION 173
16.10.1 COMPANY SNAPSHOT 173
16.10.2 PRODUCT PORTFOLIO 173
16.10.3 RECENT DEVELOPMENT 173
16.11 CIVCO RADIOTHERAPY 174
16.11.1 COMPANY SNAPSHOT 174
16.11.2 PRODUCT PORTFOLIO 174
16.11.3 RECENT DEVELOPMENT 175
16.12 ECKERT & ZIEGLER BEBIG 176
16.12.1 COMPANY SNAPSHOT 176
16.12.2 RECENT FINANCIALS 176
16.12.3 PRODUCT PORTFOLIO 177
16.12.4 RECENT DEVELOPMENT 177
16.13 HITACHI, LTD. 178
16.13.1 COMPANY SNAPSHOT 178
16.13.2 REVENUE ANALYSIS 178
16.13.3 PRODUCT PORTFOLIO 179
16.13.4 RECENT DEVELOPMENT 179
16.14 INTRAOP MEDICAL, INC. 180
16.14.1 COMPANY SNAPSHOT 180
16.14.2 PRODUCT PORTFOLIO 180
16.14.3 RECENT DEVELOPMENT 181
16.15 ISORAY INC. 182
16.15.1 COMPANY SNAPSHOT 182
16.15.2 REVENUE ANALYSIS 182
16.15.3 PRODUCT PORTFOLIO 183
16.15.4 RECENT DEVELOPMENT 183
16.16 KONINKLIJKE PHILIPS N.V. 184
16.16.1 COMPANY SNAPSHOT 184
16.16.2 REVENUE ANALYSIS 184
16.16.3 PRODUCT PORTFOLIO 185
16.16.4 RECENT DEVELOPMENT 185
16.17 MEVION MEDICAL SYSTEMS 186
16.17.1 COMPANY SNAPSHOT 186
16.17.2 PRODUCT PORTFOLIO 186
16.17.3 RECENT DEVELOPMENT 186
16.18 MIRADA MEDICAL LIMITED 187
16.18.1 COMPANY SNAPSHOT 187
16.18.2 PRODUCT PORTFOLIO 187
16.18.3 RECENT DEVELOPMENT 187
16.19 NORDION (CANADA) INC. (A SUBSIDIARY OF SOTERA HEALTH) 188
16.19.1 COMPANY SNAPSHOT 188
16.19.2 REVENUE ANALYSIS 188
16.19.3 PRODUCT PORTFOLIO 189
16.19.4 RECENT DEVELOPMENT 189
16.20 PANACEA MEDICAL TECHNOLOGIES PVT. LTD. 190
16.20.1 COMPANY SNAPSHOT 190
16.20.2 PRODUCT PORTFOLIO 190
16.20.3 RECENT DEVELOPMENT 190
16.21 P-CURE 191
16.21.1 COMPANY SNAPSHOT 191
16.21.2 PRODUCT PORTFOLIO 191
16.21.3 RECENT DEVELOPMENT 191
16.22 PROTOM INTERNATIONAL 192
16.22.1 COMPANY SNAPSHOT 192
16.22.2 PRODUCT PORTFOLIO 192
16.22.3 RECENT DEVELOPMENT 192
16.23 PROVISION HEALTHCARE 193
16.23.1 COMPANY SNAPSHOT 193
16.23.2 PRODUCT PORTFOLIO 193
16.23.3 RECENT DEVELOPMENT 193
16.24 RAYSEARCH LABORATORIES 194
16.24.1 COMPANY SNAPSHOT 194
16.24.2 REVENUE ANALYSIS 194
16.24.3 PRODUCT PORTFOLIO 195
16.24.4 RECENT DEVELOPMENT 195
16.25 SIT - S.I.T. SORDINA IORT TECHNOLOGIES S.P.A. 196
16.25.1 COMPANY SNAPSHOT 196
16.25.2 PRODUCT PORTFOLIO 196
16.26 SUMITOMO HEAVY INDUSTRIES, LTD. 197
16.26.1 COMPANY SNAPSHOT 197
16.26.2 REVENUE ANALYSIS 197
16.26.3 PRODUCT PORTFOLIO 198
16.26.4 RECENT DEVELOPMENT 198
16.27 VIEWRAY TECHNOLOGIES, INC. (VIEWRAY) 199
16.27.1 COMPANY SNAPSHOT 199
16.27.2 RECENT FINANCIALS 199
16.27.3 PRODUCT PORTFOLIO 200
16.27.4 RECENT DEVELOPMENT 200
16.28 XOFT, A SUBSIDIARY OF ICAD, INC. 201
16.28.1 COMPANY SNAPSHOT 201
16.28.2 REVENUE ANALYSIS 201
16.28.3 PRODUCT PORTFOLIO 202
16.28.4 RECENT DEVELOPMENT 202
16.29 ZEISS INTERNATIONAL 203
16.29.1 COMPANY SNAPSHOT 203
16.29.2 PRODUCT PORTFOLIO 203
16.29.3 RECENT DEVELOPMENT 203
17 QUESTIONNAIRE 204
18 RELATED REPORTS 207
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
